Cheryl Cohen
CIK 1529371 · Chief Commercial Officer · last filed 2026-06-10
Cheryl Cohen is a Chief Commercial Officer who has filed 49 SEC Form 4 insider transactions across 9 companies since 2011. The most recent filing, for IBRX, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$7.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.53M
9
49
-$7.05M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IBRX | Director | 215,418 | $7.10 | $1.53M | -$710.4K | 8 | 2026-06-10 |
| CLDX | Director | — | $31.27 | — | $0 | 4 | 2025-06-09 |
| Lite Strategy, Inc. (MEIP) Delisted | Director | — | $3.20 | — | $0 | 4 | 2022-07-07 |
| Whitehawk Therapeutics, Inc. (ARPO) Delisted | Director | 16,160 | $33.00 | $533.3K | $0 | 6 | 2021-07-02 |
| ImmunityBio, Inc. (NK) Delisted | Director | 270,925 | — | — | -$298.8K | 3 | 2020-08-13 |
| Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Director | — | — | — | $0 | 3 | 2019-07-15 |
| Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Director | — | — | — | $0 | 2 | 2016-06-16 |
| LadRx Corp (CYTXW) Delisted | Director | — | — | — | $0 | 1 | 2015-12-17 |
| MEDIVATION, INC. (MDVN) Delisted | Chief Commercial Officer | 32,436 | — | — | -$6.05M | 11 | 2014-02-20 |
Recent Filings
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | CLDX | Grant (A) | — | $0 | EDGAR |
| 2024-06-17 | CLDX | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | CLDX | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2022-07-07 | Lite Strategy, Inc. (MEIP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | CLDX | Grant (A) | — | $0 | EDGAR |
| 2022-06-15 | IBRX | Grant (A) | — | $0 | EDGAR |